We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds.
Twist Bioscience Corporation (NASDAQ:TWST) is among the best immunology stocks
TheFly reported on May 5 that a Guggenheim analyst increased the price target on TWST from $55 to $60 while maintaining a Buy rating on the stock. The revision followed the company’s latest quarterly results and came ahead of its investor day held on May 21. The adjustment reflects updated financial estimates and expectations after recent performance data.
The analyst’s note highlighted continued positive sentiment toward the company’s outlook, with valuation changes incorporated based on the most recent earnings report and upcoming strategic presentation to investors. Twist Bioscience Corporation (NASDAQ:TWST) reported its fiscal second quarter 2026 financial results on May 4, 2026, covering the period ended March 31, 2026. The company recorded revenue of $110.7 million, representing 19% year-over-year growth, driven by gains in both DNA Synthesis and Protein Solutions as well as NGS Applications.